| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 8,050 | 8,150 | 01.09. | |
| 8,100 | 8,250 | 01.09. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Exklusiv: CEO von Axe Compute - Vorauszahlungen decken rund ein Drittel der Baukosten von 3 Mrd. USD | 1 | Investing.com Deutsch | ||
| 18.08. | Axe Compute Inc: Axe Compute Receives $317 Million in Customer Prepayments Under Global AI Infrastructure Contracts | 317 | GlobeNewswire (Europe) | PITTSBURGH, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Axe Compute Inc. (NASDAQ: AGPU) today announced it has received over $317 million in customer prepayments under the more than $3 billion in AI infrastructure... ► Artikel lesen | |
| 18.08. | Duos outlines 2027 revenue of at least $160M as Axe Compute expands to 55 MW | 1 | Seeking Alpha | ||
| 17.08. | Axe Compute targets $2B in additional contract signings by end of 2026 as annualized run rate is expected north of $696M | 1 | Seeking Alpha | ||
| 17.08. | Axe Compute and Duos Technologies sign 55MW capacity agreement | 3 | DatacenterDynamics | ||
| 17.08. | Axe Compute Q2 2026 slides: $3B+ contracts signed, $696M ARR targeted | 1 | Investing.com | ||
| 17.08. | Mitschrift des Earnings Call: Umsatz von Axe Compute springt in Q2 2026 an, Aktie steigt um 5,4 % | 1 | Investing.com Deutsch | ||
| AXE COMPUTE Aktie jetzt für 0€ handeln | |||||
| 17.08. | Axe Compute, Duos add up to 55 MW of AI data center capacity | 2 | Seeking Alpha | ||
| 17.08. | Duos Technologies Group, Inc: Duos Technologies Signs Five-Year, 55 MW Hosting Agreements with Axe Compute Valued at Over $500 Million | 3 | GlobeNewswire (USA) | ||
| 17.08. | Axe Compute Inc: Axe Compute and Duos Technologies Enter into Agreements For 55 MW of New AI Data Center Capacity Across Multiple U.S. Locations | 327 | GlobeNewswire (Europe) | PITTSBURGH and JACKSONVILLE, Fla., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Axe Compute Inc. (Nasdaq: AGPU), a neocloud AI infrastructure company delivering dedicated, bare-metal GPU compute and large-scale... ► Artikel lesen | |
| 14.08. | Axe Compute Inc. Reports Second Quarter 2026 Financial Results and Provides Business Update | 325 | GlobeNewswire (Europe) | Revenue Grew More Than 90x Sequentially from Q1 2026 in the First Full Quarter of Compute Operations More Than $2.8 Billion in New Contracts Signed, Bringing 2026 Signed Contracted Value to More Than... ► Artikel lesen | |
| 14.08. | Axe Compute Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 14.08. | Axe Compute Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 29.07. | Axe Compute secures $1.5bn compute contract with unnamed customer | 2 | DatacenterDynamics | ||
| 29.07. | A $1.5 Billion Reason to Buy Axe Compute Stock | 2 | Barchart.com | ||
| 27.07. | Axe Compute jumps after securing $1.5B AI infrastructure contract | 1 | Seeking Alpha | ||
| 27.07. | Axe Compute Inc: Axe Compute Secures $1.5 Billion Five-Year Dedicated AI Infrastructure Contract, Surpassing $3 Billion in 2026 Signed Contracted Value | 372 | GlobeNewswire (Europe) | Five-year, $1.5 billion B300 cluster contract lifts 2026 signed contracts above $3 billion and is expected to increase ARR to roughly $696 million.More than $534 million in cash prepayments power... ► Artikel lesen | |
| 22.07. | Axe Compute secures over $1.3B in AI infrastructure contracts; tops 2026 target | 1 | Seeking Alpha | ||
| 22.07. | Axe Compute secures $1.3 billion in AI infrastructure contracts | 4 | Investing.com | ||
| 22.07. | Axe Compute Inc: Axe Compute Secures Over $1.3 Billion in Global AI Infrastructure Customer Contracts | 403 | GlobeNewswire (Europe) | Axe Compute sees surging enterprise demand for dedicated, large-scale AI infrastructure, on a global scale, far exceeding its goal of $1 billion in signed contracts midway through 2026. PITTSBURGH... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 44,785 | -1,02 % | EQS-News: Schutzgemeinschaft der Kapitalanleger e.V.: Fresenius, Gerresheimer, TUI und viele weitere Unternehmen präsentieren sich im Rahmen der SdK-Anlegerforen | Emittent / Herausgeber: Schutzgemeinschaft der Kapitalanleger e.V.
/ Schlagwort(e): Konferenz/Konferenz
Fresenius, Gerresheimer, TUI und viele weitere Unternehmen präsentieren... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,540 | +0,23 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| DRAEGERWERK | 114,80 | +2,14 % | Drägerwerk Aktie: Die Margenstory gewinnt an Kraft | Die Aktienanalysten bei mwb research werden für Drägerwerk optimistischer und heben das Kursziel für die Aktie von 114 Euro auf 130 Euro an. Die Kaufempfehlung für den TecDAX-Titel bleibt bestehen.... ► Artikel lesen | |
| GERRESHEIMER | 27,380 | -2,63 % | Gerresheimer-Aktie: Ist ein Kursziel von 40 € gerechtfertigt? | Die Gerresheimer-Aktie konnte sich nach dem starken Kursverlust seit September vergangenen Jahres zuletzt deutlich erholen. Zuletzt bewegte sich das Papier jedoch orientierungslos in einer Handelsspanne... ► Artikel lesen | |
| TELADOC HEALTH | 5,482 | +1,56 % | Teladoc Health, Inc. - 8-K, Current Report | ||
| HIMS & HERS HEALTH | 24,560 | 0,00 % | Hims & Hers launches online prescriptions in Australia after Eucalyptus deal | ||
| M1 AESTHETICS | 12,900 | +0,78 % | Dividendenbekanntmachungen (08.07.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A2 MILK COMPANY LIMITED NZATME0002S8 0,4135 NZD 0,2059 EUR AGRANA BETEILIGUNGS-AG AT000AGRANA3 - 0,35 EUR BANK OF CHONGQING CO LTD CNE100001QN2 0... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,067 | -4,84 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy | TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova" or the "Company") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused... ► Artikel lesen | |
| SYNLAB | - | - | EQS-News: SYNLAB: Synnovis milestone: 2,000 revolutionary blood tests for NHS lung and breast cancer patients | EQS-News: SYNLAB
/ Key word(s): Miscellaneous
Synnovis milestone: 2,000 revolutionary blood tests for NHS lung and breast cancer patients
10.08.2026 / 09:00 CET/CEST
The... ► Artikel lesen | |
| CERENOME | 2,270 | -5,61 % | Cerenome, Inc.: Cerenome Reports Second Quarter 2026 Financial Results and Business Update | HOUSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), a CNS oncology company advancing an integrated platform that combines precision diagnostics... ► Artikel lesen | |
| CARDINAL HEALTH | 206,70 | +0,10 % | Catheter Precision, Inc.: Catheter Precision Achieves Major Commercial Milestones with Cardinal Health, Johns Hopkins and the placement of the First VIVO System in Germany | Received First LockeT Purchase Order Through Cardinal Health which serves approximately 90% of U.S. Hospitals though its Medical Products business Johns Hopkins Hospital, a world-renowned academic... ► Artikel lesen | |
| HEALWELL AI | 0,502 | +1,01 % | Healwell AI Inc: Healwell AI to roll out Smart tools on Iowa HIE | ||
| SIEMENS HEALTHINEERS | 39,300 | +0,43 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| HEARTFLOW | 50,53 | +0,20 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| GENEDX | 84,81 | 0,00 % | GeneDx study shows rapid genome sequencing benefits beyond ICUs |